Co-Diagnostics (CODX)

• Market cap: $23.8M
• 1 day: 0.66%
• 5 days: 1.07%
• 1 month: 2.99%
• 3 months: 56.17%
• 6 months: 15.98%
• Year to date: -45.17%
• 1 year: -66.14%
• 5 years: -97.39%
• 10 years: -93.18%
• Sector: Healthcare
• Industry: Medical Devices

About: Co-Diagnostics Inc is a molecular diagnostics company. It develops, licenses, and commercializes molecular technologies such as lab systems (MDx device) and manufacture and sell reagents used for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). CDI's low-cost system uses its tests to diagnose tuberculosis, Zika, hepatitis B and C, Malaria, dengue and HIV.The Company's technologies are utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR platform and to locate genetic markers for use in applications other than infectious diseases.

Employees: 132